首页> 外文OA文献 >Clotrimazole scaffold as an innovative pharmacophore towards potent antimalarial agents: Design, synthesis, and biological and structure-activity relationship studies
【2h】

Clotrimazole scaffold as an innovative pharmacophore towards potent antimalarial agents: Design, synthesis, and biological and structure-activity relationship studies

机译:克霉唑支架作为针对有效抗疟药的创新药效基团:设计,合成以及生物学和结构活性关系研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We describe herein the design, synthesis, biological evaluation, and structure-activity relationship (SAR) studies of an innovative class of antimalarial agents based on a polyaromatic pharmacophore structurally related to clotrimazole and easy to synthesize by low-cost synthetic procedures. SAR studies delineated a number of structural features able to modulate the in vitro and in vivo antimalarial activity. A selected set of antimalarials was further biologically investigated and displayed low in vitro toxicity on a panel of human and murine cell lines. In vitro, the novel compounds proved to be selective for free heme, as demonstrated in the beta-hematin inhibitory activity assay, and did not show inhibitory activity against 14-alpha-lanosterol demethylase (a fungal P450 cytochrome). Compounds 2, 4e, and 4n exhibited in vivo activity against P. chabaudi after oral administration and thus represent promising antimalarial agents for further preclinical development.
机译:我们在本文中描述了创新类抗疟药的设计,合成,生物学评估和结构-活性关系(SAR)研究,该类抗疟药基于与克霉唑相关的且易于通过低成本合成程序合成的多芳香族药效团。 SAR研究描述了许多能够调节体外和体内抗疟活性的结构特征。进一步对一组选定的抗疟药进行了生物学研究,结果显示其对一组人和鼠细胞系的体外毒性较低。在体外,新的化合物被证明对游离血红素具有选择性,如在β-血红素抑制活性试验中所证实的,并且对14-α-羊毛甾醇脱甲基酶(一种真菌P450细胞色素)没有抑制活性。口服给药后,化合物2、4e和4n表现出对Chabaudi沙门氏菌的体内活性,因此代表了有希望的抗疟药,可用于进一步的临床前开发。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号